The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the continued support of the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC). The AADCRC program serves as the cornerstone of NIAID's efforts to promote clinical and basic research in diseases including asthma, upper airway allergic/inflammatory diseases, food and drug allergies, atopic dermatitis, and other allergic diseases. The overarching goals of this program are to investigate mechanisms underlying the onset, progression, treatment modalities, and mechanisms of treatment response for the diseases of interest. Goals of the program may include exploring disease mechanisms and/or treatment modalities in small clinical trials/observational studies or immune pathway-focused projects using primarily human materials. The AADCRC is the only NIAID program that is designed to promote multi-center, multidisciplinary, translational research in asthma and allergic diseases. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Government

• County governments
• Special district governments
• State governments
• Federally recognized Native American tribal governments
• Public and Indian housing authorities
• City or township governments

Education

• Public and state institutions of higher education
• Private institutions of higher education
• Independent school districts

Nonprofit

• Nonprofits non-higher education without 501(c)(3)
• Nonprofits non-higher education with 501(c)(3)
• Other Native American tribal organizations

Business

• Small businesses
• For-profit organizations other than small businesses

Miscellaneous

• Other